Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001180404 | SCV001345331 | likely benign | Cardiomyopathy | 2018-11-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001442575 | SCV001645526 | likely benign | Hypertrophic cardiomyopathy | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409103 | SCV002716408 | likely benign | Cardiovascular phenotype | 2020-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001442575 | SCV004842428 | likely benign | Hypertrophic cardiomyopathy | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005056641 | SCV005726239 | likely benign | not specified | 2024-11-15 | criteria provided, single submitter | clinical testing |